Access the updated page using the API Locator.   Our Custom Search for Pharma News…

FDA Approval Activities for this Drug… NIMOTOP (nimodipine) Capsules,30 mg, Bayer Pharmaceutical Division NDA 18-869/S10 8/22/00 8/23/00 8/23/00 NIMOTOP (nimodipine) Capsules,Rx Bayer Pharmaceutical Division NDA 18-869 8/22/00 Nimotop Indications: for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranialberry aneurysms regardless of their post-ictus neurologic condition. | Nimotop (Nimodipine) capsules, Bayer Pharma, Labeling Revision | Nimodipine Capsules, Sun Pharma, Approval | Nimodipine Capsules, Barr Labs, Approval | Nimodipine Capsules, Banner Pharmacaps, Approval View updates.                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | VOIP © 2012 Betterchem.com